bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.05.09.593305

HighDimMixedModels.jl: Robust High Dimensional Mixed Models across Omics Data

Abstract

High dimensional mixed-effect models are an increasingly important form of regression in modern biology, in which the number of variables often matches or exceeds the number of samples, which are collected in groups or clusters. The penalized likelihood approach to fitting these models relies on a coordinate gradient descent (CGD) algorithm that lacks guarantees of convergence to a global optimum. Here, we study empirically the behavior of the algorithm across a number of common study types in modern omics datatypes. In particular, we study the empirical performance of high dimensional mixed-effect models fit to data simulated to mimic the features of transcriptome, genome-wide association, and microbiome data. In addition, we study the performance of the model on real data from each of these study types. To facilitate these simulations, we implement the algorithm in an open source Julia package HighDimMixedModels.jl. We compare the performance of two commonly used penalties, namely LASSO and SCAD, within the HighDimMixedModels.jl framework. Our results demonstrate that the SCAD penalty consistently outperforms LASSO in terms of both variable selection and estimation accuracy across omics data. Through our comprehensive analysis, we illuminate the intricate relationship between algorithmic behavior, penalty selection, and dataset properties such as the correlation structure among features, providing valuable insights for researchers employing high dimensional mixed-effect models in biological investigations. Author SummaryHigh dimensional mixed-effect models are increasingly indispensable in modern biology, particularly in omics studies, where the number of variables often equals or surpasses the number of samples, and data are collected in clusters or groups. In our research, we concentrate on the penalized likelihood approach to fitting these models, employing a coordinate gradient descent (CGD) algorithm. While CGD is a widely used optimization technique, its convergence to a global optimum lack guarantees, prompting our empirical investigation into its behavior across various study types common in modern omics datasets. Our study provides insights into the performance of high dimensional mixed-effect models fitted to data simulating transcriptome, genome-wide association, and microbiome datasets. Additionally, we evaluate the models performance on real datasets from each of these study types. To facilitate reproducibility and further research, we have implemented the algorithm in an open-source Julia package, HighDimMixedModels.jl. Notably, HighDimMixedModels.jl stands out as the first package capable of seamlessly handling various omics datasets without errors, offering a user-friendly solution for researchers across disciplines. While numerous software packages are available for implementing high dimensional mixed-effects models on omics data, there is currently no comprehensive review source summarizing all methods. We provide a table summarizing existing methods, available in the Supplementary Material.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gorstein, E., Aghdam, R., Solis-Lemus, C.. 2024-05-10. HighDimMixedModels.jl: Robust High Dimensional Mixed Models across Omics Data. https://doi.org/10.1101/2024.05.09.593305

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology↗

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology↗

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology↗